Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose lithium in children with ADHD
ChiCTR2400089288Phase 2Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Zhengzhou University
- Start
- Sep 2024
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of lithium in attention deficit hyperactivity disorder (ADHD) (4 arms), sponsored by The Third Affiliated Hospital of Zhengzhou University. Primary endpoints: Near infrared functional brain imaging, ADHD-RS and 2 more. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
lithium
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on ChiCTR2400089288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089288.